title: Assessment of human islet viability using various mouse models.
abstract: To date no in vitro viability test is known to accurately predict in vivo human islet function, making transplantation into various nonimmune animal models mandatory. The diabetic mouse model has been proposed as a standard method for human islet viability assessment. However, the use of streptozotocin for diabetes induction is associated with inconsistency with respect to induction protocols and the significant mortality rate. The purpose of this study was to compare a nondiabetic NOD-scid mouse model to its diabetic counterpart in terms of predicting islet viability. Diabetes was induced in NOD-scid mice using intraperitoneal injection of streptozotocin at concentrations ranging from 100 to 200 mg/kg. Blood glucose levels were monitored for 7 to 10 days, and mice that had levels of >300 mg/dL were used in the experiment. For nondiabetic mice, blood glucose and baseline human C-peptide levels were checked after an overnight fast. Transplantation of 2000 human islet equivalent was done in both models using the same technique. Islet function was determined in the diabetic mice by return to normoglycemia for 2 consecutive days and measurement of fasting human C-peptide on days 7 and 14 posttransplant. Viability was tested in nondiabetic mice after intraperitoneal injection of glucose (2 g/kg) and the measurement of human C-peptide levels using radioimmunoassay. Titration of the streptozotocin dose from 200 to 100 mg/kg showed a significant reduction in mice mortality (40% to 10%) and an increase of diabetes induction (55% to 81%). The 23 human islet isolations tested in both models showed complete consistency of the viability results.
authors.affiliation: Department of Surgery, University of Tennessee Health Science Center, 956 Court Avenue, Memphis, TN 38103, USA.
authors.forename: O M
authors.initials: OM
authors.lastname: Sabek
authors.forename: D W
authors.initials: DW
authors.lastname: Fraga
authors.forename: O
authors.initials: O
authors.lastname: Minoru
authors.forename: J L
authors.initials: JL
authors.lastname: McClaren
authors.forename: A O
authors.initials: AO
authors.lastname: Gaber
mesh_terms: D000818:Animals; D002470:Cell Survival; D003921:Diabetes Mellitus, Experimental / Q000601:surgery; D006801:Humans; D007515:Islets of Langerhans / Q000166:cytology*; D016381:Islets of Langerhans Transplantation / Q000473:pathology / Q000502:physiology*; D051379:Mice; D016688:Mice, Inbred NOD; D016513:Mice, SCID; D023421:Models, Animal; D014183:Transplantation, Heterologous